Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

How anti-DEI healthcare policies are impacting patient care
All over the United States, countless research projects designed to improve outcomes have either lost funding or been forced to shut down. Even screening efforts targeting patients in impoverished communities have been impacted by these policies.
New AI-enabled, helium-free MRI system earns FDA clearance
The scanner requires just 0.7 liters of liquid helium for cooling—a fraction of the more than 1,500 liters standard systems need to operate safely.
FDA finalizes new heart warnings for COVID-19 vaccines
The new warnings, first proposed to Pfizer and Moderna in April, are now officially required by the FDA. They provide additional information about the potential risks of myocarditis and/or pericarditis associated with these vaccines.
Radiologists call for ‘urgent’ update to payer policy they say is based on bogus info
The Society of Interventional Radiology and five additional doc groups recently voiced their displeasure in a letter to Elevance Health.
Administration lifts pause on visa processing, prioritizing foreign-born radiologists and other docs
“IMGs play an essential role in filling workforce shortages in areas and specialties that struggle to recruit and retain physicians,” ACR said Wednesday.

The first Black American College of Cardiology (ACC) president Kim Allan Williams, Sr., MD, MACC, MASNC, FAHA, FESC, chair, department of medicine, University of Louisville School of Medicine, explains the impact of Trump administration restrictions on diversity equity and inclusion (DEI) on healthcare programs and clinical trials that address women, minority and low-income patients.

How anti-DEI healthcare policies are impacting patient care

All over the United States, countless research projects designed to improve outcomes have either lost funding or been forced to shut down. Even screening efforts targeting patients in impoverished communities have been impacted by these policies.

Siemens Healthineers 1.5T helium-free MRI scanner

New AI-enabled, helium-free MRI system earns FDA clearance

The scanner requires just 0.7 liters of liquid helium for cooling—a fraction of the more than 1,500 liters standard systems need to operate safely.

FDA finalizes new heart warnings for COVID-19 vaccines

The new warnings, first proposed to Pfizer and Moderna in April, are now officially required by the FDA. They provide additional information about the potential risks of myocarditis and/or pericarditis associated with these vaccines.

Radiologists call for ‘urgent’ update to payer policy they say is based on bogus info

The Society of Interventional Radiology and five additional doc groups recently voiced their displeasure in a letter to Elevance Health.

passport visa foreign international travel

Administration lifts pause on visa processing, prioritizing foreign-born radiologists and other docs

“IMGs play an essential role in filling workforce shortages in areas and specialties that struggle to recruit and retain physicians,” ACR said Wednesday.

FDA announces recall of device used in interventional procedures after 3 injuries

The action applies to Cook Medical’s Beacon Tip Catheters, used for angiographic procedures, with concerns the tip can fragment in the patient, causing potential harm.

Medicaid and SNAP cuts could lead to 1.2M lost jobs by 2029, report finds

The healthcare sector will suffer the most if the federal Medicaid cuts proposed in Congress are enacted, the Commonwealth Fund said. According to the group’s analysis, hospitals, nursing homes, and clinics could be forced to shut their doors.

All 50 states agree to $7.4B opioid crisis settlement

The legal case brought by all 50 states, Washington D.C., and multiple U.S. territories against Purdue Pharma and the Sackler family has come to an end, with settlement funds set to be used for addiction recovery.